Is a complete NSE/PPLPHARMA research report available?

No complete published report is available for nse/PPLPHARMA (NSE/PPLPHARMA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/PPLPHARMA stock profile: metrics, valuation and analysis

Market cap	280.9B
Revenue (ttm)	92.1B
Net income (ttm)	-3.1B
EPS (ttm)	-₹2.36
Shares out	1.3B
P/E (forward)	92.7x
Dividend	₹0.14 (0.07%)
Volume	3,407,321
Beta	0.33

All NSE/PPLPHARMA indicators

Market & fundamental data

Available fields

189

Groups with data

Currency

INR

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	7,120
Employees Change	1,644%
Employees Change Percent	30.02
Enterprise value	INR 324.5B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.23
Industry PE Fwd	33.61
Isin	INE0DK501011
Last refreshed	2026-09-13
Market cap	INR 280.9B
Price	INR 212
Price currency	INR
Rev Per Employee	12,928,778.09x
Sector	Healthcare
Sector PE	47.65
Sector PE Fwd	37.98
Sic	2834
Symbol	nse/PPLPHARMA
Website	https://www.piramalpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.12%
EV/EBIT	150.16x
EV/EBITDA	32.36x
EV/FCF	42.55x
EV/Sales	3.53x
FCF yield	2.71%
Forward P/E	92.7x
P/B ratio	3.44x
P/S ratio	3.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.72%
EBITDA Margin	9.75%
FCF margin	8.6%
Gross margin	59.41%
Gross Profit	INR 54.7B
Gross Profit Growth	-1.61%
Gross Profit Growth Q	14.36%
Gross Profit Growth3 Y	7.64%
Net Income	INR -3.1B
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-1.14%
Profit Margin	-3.41%
Profit Per Employee	INR -440,492
Roa5y	1.52
Roe5y	0.14
ROIC	1.26
Roic5y	1.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	6.18%
Cagr3y	26.04%
EPS Growth Quarters	1
EPS Growth Years	0
FCF Growth	234.58%
OCF Growth	85.21%
OCF Growth3 Y	50.59%
Revenue Growth	0.78x
Revenue Growth Q	17.39x
Revenue Growth Qo Q	-17.51x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	7.5x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 13.6B
Debt	INR 57.1B
Debt EBITDA	INR 6.05
Debt Equity	INR 0.7
Debt FCF	INR 7.49
Equity	INR 81.6B
Interest Coverage	0.46
Net Cash	INR -43.6B
Net Cash By Market Cap	INR -15.51
Net Debt EBITDA	INR 4.85
Net Debt Equity	INR 0.53
Net Debt FCF	INR 5.71
Tangible Book Value	INR 40.2B
Tangible Book Value Per Share	INR 30.3
WACC	5.86

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.01%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	INR 0.14
Dividend Years	2
Dividend Yield	0.07%
Ex Div Date	2025-07-16
Last Dividend	INR 0.14
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	6.18%
200-day SMA	172.6
3Y total return	100.28%
50-day SMA	199.6
50-day SMA vs 200-day SMA	50over200
All Time High	307.9
All Time High Change	-31.31%
All Time High Date	2024-11-06
All Time Low	63.1
All Time Low Change	235.18%
All Time Low Date	2023-03-28
ATR	7.51
Beta	0.33
Beta1y	0.48
Beta2y	0.51
Ch YTD	22.82
High	214.5
High52	231.9
High52 Date	2026-09-08
High52ch	-8.81%
Low	208.7
Low52	132.3
Low52 Date	2026-03-23
Low52ch	59.86%
Ma50ch	5.97%
Price vs 200-day SMA	22.5%
RSI	51.08
RSI Monthly	57.3
RSI Weekly	65.75
Sharpe ratio	0.2x
Sharpe Ratio3y	0.74x
Sortino ratio	0.49
Sortino Ratio3y	1.36
Total Return	0.05%
Tr YTD	22.82
Tr1m	-0.99%
Tr1w	-1.27%
Tr3m	28.91%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	612,734,310%
Net Borrowing	2,829,600,000
Shares Insiders	0.2%
Shares Institutions	23.66%
Shares Out	1,329,263,488
Shares Qo Q	5.91%
Shares Yo Y	0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR 7.2B
Adjusted OCF	16,108,700,000
Average Volume	4,429,000.65x
Bv Per Share	61.5
CAPEX	INR -8.9B
Ch1m	-0.99
Ch1w	-1.27
Ch1y	6.18
Ch3m	28.91
Ch3y	100
Ch6m	36.13
Change	-0.47%
Change From Open	0.43
Close	212.5
Days Gap	-0.89
Depreciation Amortization	7,399,800,000
Dollar Volume	720,648,391.5
Earnings Date	2026-10-29
EBIT	INR 1.6B
EBITDA	INR 9B
EPS	INR -2.36
F Score	2
FCF	INR 7.6B
FCF EV Yield	2.35x
FCF Per Share	INR 5.74
Financing CF	-389,800,000
Fiscal Year End	March
Founded	2,020
Income Tax	INR 2.1B
Investing CF	-8,260,300,000
Is Primary Listing	1
Last Earnings Date	2026-07-29
Last Report Date	2026-06-30
Ma150	173.2
Ma150ch	22.1%
Ma20	213.9
Ma20ch	-1.1%
Net CF	7,939,400,000
Next Earnings Date	2026-10-29
Open	210.6
P FCF Ratio	36.84
P FCF Ratio SBC	38.97
P OCF Ratio	17
P OCF Ratio SBC	17.44
Payment Date	2025-08-29
Position In Range	48.87
Price Date	2026-09-11
Price EBITDA	INR 31.29
Ptbv Ratio	6.99
Relative Volume	0.78x
Revenue	92,052,900,000x
SBC By Revenue	0.47x
Share Based Comp	417,200,000
Tax By Revenue	2.27x
Tr6m	36.13%
Volume	3,407,321

NSE/PPLPHARMA (NSE/PPLPHARMA)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/PPLPHARMA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/PPLPHARMA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/PPLPHARMA

Frequently asked questions